HLS.TO · HLS Therapeutics Inc.
Canada · RS rating 34 · As of 2026-10-14
| Price | 4.10 CAD |
|---|---|
| 1-day change | +1.2% |
| RS rating (overall / 1M / 3M / 12M) | 34 / 51 / 50 / 24 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 36 / 16 / 67 |
| Industry group (rank) | Medical-Generic Drugs (45) |
| EPS growth Q/Q | +57.1% |
| Sales growth Q/Q | +14.1% |
| Distance from 52-week high | +27.3% |
| Market cap (USD) | $88.9M |